Latest & greatest articles for Pacemaker

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Pacemaker or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Pacemaker and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Pacemaker

1. Infections Associated with Resterilized Pacemakers and Defibrillators. (Abstract)

Infections Associated with Resterilized Pacemakers and Defibrillators. Access to pacemakers and defibrillators is problematic in places with limited resources. Resterilization and reuse of implantable cardiac devices obtained post mortem from patients in wealthier nations have been undertaken, but uncertainty around the risk of infection is a concern.A multinational program was initiated in 1983 to provide tested and resterilized pacemakers and defibrillators to underserved nations (...) %). Overall, 85% received pacemakers and 15% received defibrillators, with one (55.5%), two (38.8%), or three (5.7%) leads. Baseline characteristics did not differ between these patients and the 3153 matched control patients. At 2 years of follow-up, infections had occurred in 21 patients (2.0%) with reused devices and in 38 (1.2%) with new devices (hazard ratio, 1.66; 95% confidence interval, 0.97 to 2.83; P = 0.06); there were no device-related deaths. The most common implicated pathogens were

2020 NEJM

2. The complementary effects of galvanic current electrical stimulation associated with conservative treatment to increase vasodilation in patients with Raynaud`s phenomenon: a randomized trial

The complementary effects of galvanic current electrical stimulation associated with conservative treatment to increase vasodilation in patients with Raynaud`s phenomenon: a randomized trial The Complementary Effects of Galvanic Current Electrical Stimulation Associated With Conservative Treatment to Increase Vasodilation in Patients With Raynaud's Phenomenon: A Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Clin Rehabil Actions . 2020 May;34(5):595-606. doi: 10.1177/0269215520907652. Epub 2020 Mar 6. The Complementary Effects of Galvanic Current Electrical Stimulation Associated With Conservative Treatment to Increase Vasodilation in Patients With Raynaud's Phenomenon: A Randomized Trial , , , , , Affiliations Expand Affiliations 1 Instituto de

2020 EvidenceUpdates

3. Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial Full Text available with Trip Pro

Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National (...) Permalink Copy Page navigation Gastroenterology Actions . 2020 Feb;158(3):506-514.e2. doi: 10.1053/j.gastro.2019.10.018. Epub 2019 Oct 21. Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial , , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators ENTERRA Research Group : , , , , , , , , , , , , , , , , , , Affiliations 1 Rouen University Hospital-Inserm UMR 1073/Inserm CIC-CRB 1404, Rouen, France. 2 Paris-HP Louis Mourier

2020 EvidenceUpdates

4. Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial (Abstract)

Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial Supervised exercise programmes for intermittent claudication have poor access and limited compliance. Neuromuscular electrical stimulation (NMES) may be an effective alternative. A proof-of-concept study and RCT were conducted.In study 1, eligible patients underwent baseline assessment; treadmill testing (...) for initial (ICD) and maximum (MCD) claudication distance; EuroQoL Five Dimensions five-level instrument (EQ-5D-5L™) and Intermittent Claudication Questionnaire (ICQ) assessment; and measurement of ultrasound haemodynamics of the superficial femoral artery. After familiarization with the NMES device, participants underwent a 30-min session of stimulation with concomitant recording of haemodynamic measures at 15 min, and after device cessation. Measurements were repeated after 6 weeks of daily use of NMES

2020 EvidenceUpdates

5. Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study (Abstract)

Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study The objective of the current study is to investigate the risk of heart failure (HF) after implantation of a pacemaker (PM) with a right ventricular pacing (RVP) lead in comparison to a matched cohort without a PM and factors associated with this risk.All patients without a known history of HF who had a PM implanted with an RVP lead between 2000 and 2014 (n = 27 704) were identified using (...) incidence of HF including fatal HF was observed in 2937 (10.6%) PM patients. Risks for the three time-intervals were <30 days [hazard ratio (HR) 5.98, 95% CI 5.19-6.90], 30-180 days (HR 1.84, 95% CI 1.71-1.98), and >180 days (HR 1.11, 95% CI 1.04-1.17). Among patients with a PM device, factors associated with increased risk of HF were male sex (HR 1.33, 95% CI 1.24-1.43), presence of chronic kidney disease (CKD) (HR 1.64, 95% CI 1.29-2.09), and prior MI (1.77, 95% 1.50-2.09).Pacemaker with an RVP lead

2019 EvidenceUpdates

6. Switching Between Transcutaneous Pacemakers: Guidelines

-paced adult patients who require switching to a different transcutaneous pacemaker? Key Message No relevant evidence-based guidelines were identified regarding care of transcutaneous-paced adult patients who require switching to a different transcutaneous pacemaker. Files Rapid Response Reference List Published : July 24, 2019 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter: (...) Switching Between Transcutaneous Pacemakers: Guidelines Switching Between Transcutaneous Pacemakers: Guidelines | CADTH.ca Find the information you need Switching Between Transcutaneous Pacemakers: Guidelines Switching Between Transcutaneous Pacemakers: Guidelines Last updated: July 24, 2019 Project Number: RA1055-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What are the evidence-based guidelines regarding care of transcutaneous

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

7. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Chronic pain, considered to be pain lasting more than three months, is a common and often difficult to treat condition that can significantly impact upon function and quality of life. Treatment typically includes pharmacological and non-pharmacological approaches. Transcutaneous electrical nerve stimulation (TENS) is an adjunct non-pharmacological treatment commonly recommended by clinicians (...) of TENS; or TENS delivered using different stimulation parameters.Data extraction and analysisTwo authors independently extracted relevant data, assessed review quality using the AMSTAR checklist and applied GRADE judgements where required to individual reviews. Our primary outcomes included pain intensity and nature/incidence of adverse effects; our secondary outcomes included disability, health-related quality of life, analgesic medication use and participant global impression of change.We included

2019 Cochrane

8. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) Full Text available with Trip Pro

Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months.The RM-ALONE is a multicentre (...) prospective trial that randomly assigned 445 patients in two groups, both followed by RM: the home monitoring-only (HMo) based on RM + remote interrogations (RIs) every 6 months and the HM + IO that adds in-office evaluations every 6 months to RM. Four hundred and forty-five patients were enrolled in the study, 294 PMs and 151 ICDs recipients. In the HMo group, 20% of patients experienced ≥1 major adverse cardiac event (MACE) vs. 19.5% in HM + IO group (P = 0.006 for non-inferiority). The proportion

2019 EvidenceUpdates

9. Neuromuscular Electrical Stimulation Compared to Volitional Exercise for Improving Muscle Function in Rheumatoid Arthritis: A Randomized Pilot Study Full Text available with Trip Pro

Neuromuscular Electrical Stimulation Compared to Volitional Exercise for Improving Muscle Function in Rheumatoid Arthritis: A Randomized Pilot Study The aim of this study was to compare the feasibility and effectiveness of neuromuscular electrical stimulation (NMES) with that of high-intensity volitional resistance training for improving muscle structure and function and physical function in patients with rheumatoid arthritis (RA). We also compared pre-intervention and post-intervention values

2019 EvidenceUpdates

10. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Chronic pain, considered to be pain lasting more than three months, is a common and often difficult to treat condition that can significantly impact upon function and quality of life. Treatment typically includes pharmacological and non-pharmacological approaches. Transcutaneous electrical nerve stimulation (TENS) is an adjunct non-pharmacological treatment commonly recommended by clinicians (...) of TENS; or TENS delivered using different stimulation parameters.Data extraction and analysisTwo authors independently extracted relevant data, assessed review quality using the AMSTAR checklist and applied GRADE judgements where required to individual reviews. Our primary outcomes included pain intensity and nature/incidence of adverse effects; our secondary outcomes included disability, health-related quality of life, analgesic medication use and participant global impression of change.We included

2019 Cochrane

11. Immediate Effects of Simultaneous Application of Transcutaneous Electrical Nerve Stimulation and Ultrasound Phonophoresis on Active Myofascial Trigger Points: A Randomized Controlled Trial. (Abstract)

Immediate Effects of Simultaneous Application of Transcutaneous Electrical Nerve Stimulation and Ultrasound Phonophoresis on Active Myofascial Trigger Points: A Randomized Controlled Trial. The aim of the study was to investigate the efficacy of phonophoresis with combined therapy on active myofascial trigger points.One hundred participants with acute mechanical neck pain and at least one active myofascial trigger point in the upper trapezius were randomly assigned into four equal groups.Groups

2019 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain

12. Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer

Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer Electrically stimulated intr Electrically stimulated intra av vesical chemother esical chemotherap apy y for non-muscle-in for non-muscle-invasiv vasive bladder cancer e bladder cancer Interventional procedures guidance Published: 30 January 2019 nice.org.uk/guidance/ipg638 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration (...) 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 41 1 Recommendations Recommendations 1.1 Current evidence on electrically stimulated intravesical chemotherapy for non- muscle-invasive bladder cancer shows there are no major safety concerns. Evidence on efficacy is limited in quantity and quality. Therefore, this procedure should only be used in the context of research. 1.2 Further research should include randomised

2019 National Institute for Health and Clinical Excellence - Interventional Procedures

13. The comparative efficacy of theta burst stimulation or functional electrical stimulation when combined with physical therapy after stroke: a randomized controlled trial (Abstract)

The comparative efficacy of theta burst stimulation or functional electrical stimulation when combined with physical therapy after stroke: a randomized controlled trial To study the long-term effectiveness of Theta Burst Stimulation (TBS) or Functional Electrical Stimulation (FES) combined with Physical therapy (PT) as compared to PT alone for improving arm functions in patients with acute stroke.Single blind randomized controlled trial.Outpatient clinics and inpatient wards at tertiary care

2019 EvidenceUpdates

14. Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. Full Text available with Trip Pro

Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. Schizophrenia is a severe mental disorder. While some antipsychotic medications have demonstrated efficacy in treating positive symptoms, there is no widely recognized treatment for negative symptoms, which can cause significant distress and impairment for patients with schizophrenia. Here we describe the rationale and design (...) of the STARTS study (Schizophrenia TreAtment with electRic Transcranial Stimulation), a clinical trial aimed to test the efficacy of a non-pharmacological treatment known as transcranial direct current stimulation (tDCS) for treating the negative symptoms of schizophrenia.The STARTS study is designed as a randomized, sham-controlled, double-blinded trial evaluating tDCS for the treatment of the negative symptoms of schizophrenia. One-hundred patients will be enrolled and submitted to 10 tDCS sessions over

2019 Trends in psychiatry and psychotherapy Controlled trial quality: predicted high

15. Neuromuscular electrical stimulation is feasible in patients with acute heart failure. Full Text available with Trip Pro

Neuromuscular electrical stimulation is feasible in patients with acute heart failure. In acute heart failure (AHF), immobilization is caused because of unstable haemodynamics and dyspnoea, leading to protein wasting. Neuromuscular electrical stimulation (NMES) has been reported to preserve muscle mass and improve functional outcomes in chronic disease. NMES may be effective against protein wasting frequently manifested in patients with AHF; however, whether NMES can be implemented safely (...) the feasibility criteria with following items: (i) change in systolic blood pressure (BP) > ±20 mmHg during the first session; (ii) increase in heart rate (HR) > +20 b.p.m. during the first session; (iii) development of sustained ventricular arrhythmia, atrial fibrillation (AF), and paroxysmal supraventricular tachycardia during all sessions; (iv) incidence of new-onset AF during the hospitalization period < 40%; and (v) completion of the planned sessions by >70% of patients. The criteria of feasibility were

2019 ESC heart failure Controlled trial quality: uncertain

16. Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults

Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults T T r ranscutaneous neuromuscular electrical anscutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in stimulation for oropharyngeal dysphagia in adults adults Interventional procedures guidance Published: 19 December 2018 nice.org.uk/guidance/ipg634 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration (...) 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 51 1 Recommendations Recommendations 1.1 Current evidence on transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults shows there are no major safety concerns. For adults with dysphagia after a stroke, the evidence on efficacy suggests a potential benefit, but is limited in quality and quantity. Therefore, this procedure should only

2019 National Institute for Health and Clinical Excellence - Interventional Procedures

17. Short-term effects of neuromuscular electrical stimulation and ultrasound therapies on muscle architecture and functional capacity in knee osteoarthritis: a randomized study (Abstract)

Short-term effects of neuromuscular electrical stimulation and ultrasound therapies on muscle architecture and functional capacity in knee osteoarthritis: a randomized study To determine the effects of ultrasound therapy and neuromuscular electrical stimulation (NMES) application on the muscle architecture and functional capacity in patients with knee osteoarthritis.A randomized study.A total of 60 patients with knee osteoarthritis.Participants were randomized into one of the following two

2019 EvidenceUpdates

18. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers

Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers Public Comment: Held April 5 to 26, 2018. Remote Monitoring of Implantable Cardioverter- Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers: Health Quality Ontario Recommendation FINAL RECOMMENDATION • Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommends publicly funding remote monitoring (...) for patients with implantable cardioverter-defibrillators, cardiac resynchronization therapy devices with or without a defibrillator, and permanent pacemakers RATIONALE FOR THE RECOMMENDATION There was consensus among the Ontario Health Technology Advisory Committee members that using remote monitoring improves clinical outcomes without affecting patients’ safety, it is good value for money, and patients report positive experiences with using remote monitoring. 1 Remote Monitoring of Implantable

2018 Health Quality Ontario

19. Efficiency of Neuromuscular Electrical Stimulation and Transcutaneous Nerve Stimulation on Hemiplegic Shoulder Pain: A Randomized Controlled Trial (Abstract)

Efficiency of Neuromuscular Electrical Stimulation and Transcutaneous Nerve Stimulation on Hemiplegic Shoulder Pain: A Randomized Controlled Trial To compare the efficacy of neuromuscular electrical stimulation (NMES) and transcutaneous nerve stimulation (TENS) on hemiplegic shoulder pain (HSP).This is a prospective randomized controlled trial.A rehabilitation hospital.Participants (N=90) were randomized into NMES (n=36), TENS (n=36), or control groups (n=18).NMES (15Hz, pulse width 200μs (...) ) was applied to supraspinatus and deltoids (medial and posterior parts), whereas TENS (100Hz, pulse width 100μs) was used on the same areas. The surface electrodes were placed near the motor points of the supraspinatus and medial or posterior bundle of deltoids. The 4-week treatment consisted of 20 sessions, each session composed of 1 hour of stimulation per day. Routine rehabilitation program without any stimulation was administered to the control and the NMES/TENS groups. Numerical rating scale (NRS

2018 EvidenceUpdates

20. Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial Full Text available with Trip Pro

Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial Dysphagia after stroke is common, especially in severely affected patients who have had a tracheotomy. In a pilot trial, pharyngeal electrical stimulation (PES) improved swallowing function in this group of patients. We aimed to replicate and extend this single-centre experience.We did a prospective, single (...) -blind, randomised controlled trial across nine sites (seven acute care hospitals, two rehabilitation facilities) in Germany, Austria, and Italy. Patients with recent stroke who required tracheotomy were randomly assigned to receive 3 days of either PES or sham treatment (1:1). All patients had the stimulation catheter inserted; sham treatment was applied by connecting the PES base station to a simulator box instead of the catheter. Randomisation was done via a computerised interactive system

2018 EvidenceUpdates